Sinopharm Group Co. Ltd. (01099) has released a circular announcing proposed appointments of non-executive and executive directors. The appointments will be voted on at an Extraordinary General Meeting (EGM) set for 19 December 2025 at 9:30 a.m., to be held at Meeting Room 1401 in Sinopharm Group Building, Shanghai.

According to the circular, three individuals, namely Jin Bin, Ma Yue, and Li Ying, have been nominated for non-executive director positions. All three are subject to shareholder approval and will serve until the end of the current Board session, with no remuneration expected under the company's existing guidelines for non-executive directors.

Additionally, the circular proposes the appointment of Yang Binghua as an executive director. Yang currently serves as a deputy secretary of the Party Committee within the Group. Should the nomination be approved, Yang’s term will also run through the remainder of the current Board session, following the company's standard remuneration policies for executive directors.

Shareholders registered by 16 December 2025 are eligible to attend and vote at the EGM. The circular contains detailed procedures for proxy appointments, voting, and confirmation of share ownership, ensuring that shareholders can participate fully in the upcoming vote.